ICU MEDICAL ($ICUI) posted quarterly earnings results on Thursday, August 7th. The company reported earnings of $2.10 per share, beating estimates of $1.53 by $0.57. The company also reported revenue of $543,570,000, missing estimates of $553,350,000 by $-9,780,000.
You can see Quiver Quantitative's $ICUI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ICU MEDICAL Insider Trading Activity
ICU MEDICAL insiders have traded $ICUI stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by insiders over the last 6 months:
- CHRISTIAN B. VOIGTLANDER (Chief Operating Officer) has made 0 purchases and 10 sales selling 51,857 shares for an estimated $6,967,329.
- DAVID C. GREENBERG sold 1,942 shares for an estimated $278,992
- BEN SOUSA (Chief Information Officer) sold 2,000 shares for an estimated $274,714
- VIRGINIA RUTH SANZONE (VP, General Counsel) sold 700 shares for an estimated $93,537
- ELISHA W FINNEY sold 600 shares for an estimated $83,352
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ICU MEDICAL Hedge Fund Activity
We have seen 133 institutional investors add shares of ICU MEDICAL stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 517,133 shares (-60.6%) from their portfolio in Q1 2025, for an estimated $71,809,088
- FMR LLC added 462,226 shares (+97.1%) to their portfolio in Q1 2025, for an estimated $64,184,702
- CITADEL ADVISORS LLC removed 243,083 shares (-62.1%) from their portfolio in Q1 2025, for an estimated $33,754,505
- RIVER ROAD ASSET MANAGEMENT, LLC added 212,229 shares (+inf%) to their portfolio in Q1 2025, for an estimated $29,470,118
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 211,339 shares (+inf%) to their portfolio in Q2 2025, for an estimated $27,928,448
- SCHRODER INVESTMENT MANAGEMENT GROUP added 122,183 shares (+24.4%) to their portfolio in Q1 2025, for an estimated $16,966,331
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 118,789 shares (+992.1%) to their portfolio in Q1 2025, for an estimated $16,495,040
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ICU MEDICAL Government Contracts
We have seen $244,109 of award payments to $ICUI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VISN 12 LARGE VOLUME AND PCA SMART INFUSION PUMPS: $185,000
- THIS IS A BLANKET PURCHASE AGREEMENT (BPA) TO SECURE PRICING FOR IV SOLUTIONS FOR THE PHOENIX INDIAN MEDICA...: $25,000
- FY25 NAV NNMC ED AAP 25-7135-AER LEVEL ONE RAPID INFUSER: $18,266
- CADD-SOLIS AMBULATORY: $15,843
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ICU MEDICAL Congressional Stock Trading
Members of Congress have traded $ICUI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ICU MEDICAL Analyst Ratings
Wall Street analysts have issued reports on $ICUI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Strong Buy" rating on 05/09/2025
- Keybanc issued a "Overweight" rating on 04/21/2025
To track analyst ratings and price targets for ICU MEDICAL, check out Quiver Quantitative's $ICUI forecast page.
ICU MEDICAL Price Targets
Multiple analysts have issued price targets for $ICUI recently. We have seen 2 analysts offer price targets for $ICUI in the last 6 months, with a median target of $189.0.
Here are some recent targets:
- Jayson Bedford from Raymond James set a target price of $187.0 on 05/09/2025
- Tim Rezvan from Keybanc set a target price of $191.0 on 04/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
